Differential expression of Tim-3, PD-1, and CCR5 on peripheral T and B lymphocytes in hepatitis C virus-related hepatocellular carcinoma and their impact on treatment outcomes
- 1 July 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Immunology, Immunotherapy
- Vol. 69 (7), 1253-1263
- https://doi.org/10.1007/s00262-019-02465-y
Abstract
Background and objective Activation of the immune checkpoints and expression of chemokines and chemokine receptors have been reported to promote HCC progression. This study aimed to assess the differential expression of Tim-3, PD-1, and CCR5 on peripheral blood lymphocytes from patients with HCV-related HCC and correlate their expression with the treatment outcomes. Patients and methods The study incorporated 40 patients with chronic HCV-related HCC and 40 healthy controls. Patients were radiologically assessed for hepatic focal lesions and portal vein thrombosis. Response to HCC treatment and overall survival (OS) outcomes were determined. The expression of Tim-3, PD-1, and CCR5 among CD19(+), CD4(+), and CD8(+)lymphocytes was assessed by flow cytometry. Results Higher frequencies of CD4(+)and CD8(+)cells expressing each of Tim-3 and PD-1 and PD-1(+)CD19(+)cells were observed in the HCV-related HCC patients in comparison with controls.The highest expression of Tim-3 and PD-1 was by the CD8(+)cells.Strong relations were detected among PD-1(+)CD19(+), PD-1(+)CD4(+)and PD-1(+)CD8(+)cells. Elevated levels of PD-1(+)lymphocytes were significantly associated with poor treatment response and shorter OS. Conclusion Modulation of the expression of immune checkpoints as Tim-3 and PD-1, and of CCR5 on T cells is somehow related to HCC. CD8(+)T cells expressing PD-1 were the most relevant to HCC prognosis (OS and treatment response) and could represent a promising target for immune therapy against HCC. Future studies need to focus on exploring PD-1(+)B cells and Tim-3(+)CD4(+)cells, which seem to play a significant role in the pathogenesis of HCC.This publication has 56 references indexed in Scilit:
- Circulating hematopoietic stem cells, endothelial progenitor cells and cancer stem cells in hepatocellular carcinoma patients: contribution to diagnosis and prognosisActa Oncologica, 2019
- Increased frequency and FOXP3 expression of human CD8+CD25High+ T lymphocytes and its relation to CD4 regulatory T cells in patients with hepatocellular carcinomaHuman Immunology, 2019
- Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinomaMicrobial Pathogenesis, 2019
- Immune checkpoint inhibition: prospects for prevention and therapy of hepatocellular carcinomaClinical & Translational Immunology, 2017
- B cell regulation in cancer and anti-tumor immunityCellular & Molecular Immunology, 2017
- Regulatory B Cells: Key Players in Hepatocellular Carcinoma ProgressionGastroenterology & Hepatology: Open Access, 2016
- Extra-hepatic infection of hepatitis C virus in the colon tissue and its relationship with hepatitis C virus pathogenesisJournal of Medical Microbiology, 2016
- A preventable cancerNature, 2014
- The changing pattern of epidemiology in hepatocellular carcinomaDigestive and Liver Disease, 2010
- Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesisJournal of Viral Hepatitis, 2004